References
- WHO, WHO global survey on the inclusion of cancer care in health-benefit packages 2020–2021; https://iris.who.int/bitstream/handle/10665/375828/9789240088504-eng.pdf?sequence=1
- A. Alsalman, M. A. Al-Mterin, A. Abu-Dayeh, F. Alloush, K. Murshed and E. Elkord, Associations of complete blood count parameters with disease-free survival in right-and left-sided colorectal cancer patients, J. Pers. Med. 12(5) (2022) Article ID 816 (13 pages); https://doi.org/10.3390/jpm12050816
- B. Baran, N. Mert Ozupek, N. Yerli Tetik, E. Acar, O. Bekcioglu and Y. Baskin, Difference between left-sided and right-sided colorectal cancer: A focused review of literature, Gastroenterol. Res. 11(4) (2018) 264–273; https://doi.org/10.14740/gr1062w
- H. Zhao, L. Wu, G. Yan, Y. Chen, M. Zhou, Y. Wu and Y. Li, Inflammation and tumor progression: Signaling pathways and targeted intervention, Signal Transduct. Target. Ther. . (2021) Article ID 263 (46 pages); https://doi.org/10.1038/s41392-021-00658-5
- I. A. Issa and M. Noureddine, Colorectal cancer screening: An updated review of the available options, World J. Gastroenterol. 23(28) 5086–5096; https://doi.org/10.3748/wjg.v23.i28.5086
- P. S. Virdee, I. R. Marian, A. Mansouri, L. Elhussein, S. Kirtley, T. Holt and J. Birks, The full blood count blood test for colorectal cancer detection: A systematic review, meta-analysis, and critical appraisal, Cancers 12 (2020) Article ID 2348 (37 pages); https://doi.org/10.3390/cancers12092348
- M. S. Mekić, I. Pedišić, H. Šobat, V. V. Boras, I. Kirac, L. Štefančić, M. Šekerija, B. Vrdoljak and D. Vrdoljak, The role of complete blood count parameters in patients with colorectal cancer, Acta Clin. Croat. 57(4) (2018) 624–629; https://doi.org/10.20471/acc.2018.57.04.03
- M. Stojkovic Lalosevic, A. Pavlovic Markovic, S. Stankovic, M. Stojkovic, I. Dimitrijevic, I. Radoman Vujacic, D. Lalic, T. Milovanovic, I. Dumic and Z. Krivokapic, Combined diagnostic efficacy of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV) as biomarkers of systemic inflammation in the diagnosis of colorectal cancer, Dis. Markers (2019) Article ID 6036979 (7 pages); https://doi.org/10.1155/2019/6036979
- T. Yamamoto, K. Kawada and K. Obama, Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients, Int. J. Mol. Sci. 22(15) (2021) Article ID 8002 (14 pages); https://doi.org/10.3390/ijms22158002
- W. Jia, L. Yuan, H. Ni, B. Xu and P. Zhao, Prognostic value of platelet-to-lymphocyte ratio, neutro-phil-to-lymphocyte ratio, and lymphocyte-to-white blood cell ratio in colorectal cancer patients who received neoadjuvant chemotherapy, Technol. Cancer Res. Treat. 20 (2021) 1–10; https://doi.org/10.1177/15330338211034291
- A. Braun, H. J. Anders, T. Gudermann and E. Mammadova-Bach, Platelet-cancer interplay: Molecular mechanisms and new therapeutic avenues, Front. Oncol. 11 (2021) Article ID 665534 (27 pages); https://doi.org/10.3389/fonc.2021.665534
- A. Demirović and B. Krušlin, Recommendations for histopathology report of colorectal carcinoma specimens, HAZU 530 (2017) 67–72; https://doi.org/10.21857/ygjwrc642y
- X. D. Rao, H. Zhang, Z. S. Xu, H. Cheng, W. Shen and X. P. Wang, Poor prognostic role of the pre-treatment platelet counts in colorectal cancer: A meta-analysis. Vol. 97, Medicine (Baltimore) 97(23) (2018) Article ID e10831 (7 pages); https://doi.org/10.1097/MD.0000000000010831
- X. Zhu, Y. Cao, P. Lu, Y. Kang, Z. Lin, T. Hao and Y. Song, Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer, Sci. Rep. .(1) (2018) Article ID 11814 (7 pages); https://doi.org/10.1038/s41598-018-29293-x
- Y. Y. Wu, X. Zhang, Y. Y. Qin, J. Q. Qin and F. Q. Lin, Mean platelet volume/platelet count ratio in colorectal cancer: A retrospective clinical study, BMC Cancer 19(1) (2019) Article ID 314 (7 pages); https://doi.org/10.1186/s12885-019-5504-9
- Z. Feng, H. Lin, X. Yang, S. Cao, X. Gu, Z. Zhang and W. Deng, Diagnostic value of inflammation-related indicators in distinguishing early colon cancer and adenomatous oolyps, Cancer Control. 30 (2023) 1–10; https://doi.org/10.1177/10732748231180745
- B. G. Ellis and M. R. Thompson, Factors identifying higher risk rectal bleeding in general practice, Br. J. Gen. Pract. 55(521) (2005) 949–955.
- J. Tibble, G. Sigthorsson, R. Foster, R. Sherwood, M. Fagerhol and I. Bjarnason, Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma, Gut 49(3) (2001) 402–408; doi.org/10.1136/gut.49.3.402
- W. Zheng, J. Wu, Y. Peng, J. Sun, P. Cheng and Q. Huang, Tumor-associated neutrophils in colorectal cancer development, progression and immunotherapy, Cancers 14(19) (2022) Article ID 4755 (20 pages); https://doi.org/10.3390/cancers14194755
- Z. Fan, Y. Li, Q. Zhao, L. Fan, B. Tan, J. Zuo, K. Hua and Q. Ji, Highly expressed granulocyte colony-stimulating factor (G-CSF) and granulocyte colony-stimulating factor receptor (G-CSFR) in human gastric cancer leads to poor survival, Med. Sci. Monit. 24 (2018) 1701–1711; https://doi.org/10.12659/MSM.909128
- J. Yang, X. Guo, M. Wang, X. Ma, X. Ye and P. Lin, Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS, Sci. Rep.. (1) (2017) Article ID 17166 (9 pages); https://doi.org/10.1038/s41598-017-17130-6
- T. Sunaga, S. Suzuki, M. Kogo, T. Kurihara, S. Kaji, N. Koike, N. Harada, M. Suzuki and Y. Kiuchi, The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy, Eur. J. Cancer Care 23(3) (2014) 394–400; https://doi.org/10.1111/ecc.12120
- P. H. Cashin, L. Ghanipour, M. Enblad and D. L. Morris, Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study, World J. Gastrointest. Oncol. 12(5) (2020) 549–558; https://doi.org/10.4251/wjgo.v12.i5.549
- S. Hamauchi, K. Yamazaki, T. Masuishi, Y. Kito, A. Komori, T. Tsushima, Y. Narita, A. Todaka, M. Ishihara, T. Yokota, T. Tanaka, N. Machida, S. Kadowaki, A. Fukutomi, T. Ura, Y. Onozawa, M. Ando, M. Tajika, K. Muro, H. Yasui, K. Mori and H. Taniguchi, Neutropenia as a predictive factor in meta-static colorectal cancer treated with TAS-102, Clin. Colorectal Cancer 16(1) (2017) 51–57; https://doi.org/10.1016/j.clcc.2016.07.005
- H. Reichman, D. Karo-Atar and A. Munitz, Emerging roles for eosinophils in the tumor microenvironment, Trends Cancer .(11) (2016) 664–675; https://doi.org/doi:10.1016/j.trecan.2016.10.002
- G. Hu, S. Wang, K. Zhong, F. Xu, L. Huang, W. Chen and P. Cheng, Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: A meta-analysis, BMC Cancer 20(1) (2020) Article ID 454 (9 pages); https://doi.org/10.1186/s12885-020-06966-3
- G. Varricchi, M. R. Galdiero, S. Loffredo, V. Lucarini, G. Marone, F. Mattei, G. Marone and G. Schiavoni, Eosinophils: The unsung heroes in cancer? Oncoimmunology .(2) (2018) Article ID e1393134 (12 pages); https://doi.org/10.1080/2162402X.2017.1393134
- Y. Rosman, T. Hornik-Lurie, K. Meir-Shafrir, I. Lachover-Roth, A. Cohen-Engler, A. Munitz and R. Confino-Cohen, Changes in peripheral blood eosinophils may predict colorectal cancer – A retrospective study, World Allergy Organization J. 15(10) (2022) Article ID 100696 (8 pages); https://doi.org/doi:10.1016/j.waojou.2022.100696
- J. C. Chan, D. L. Chan, C. I. Diakos, A. Engel, N. Pavlakis, A. Gill and S. J. Clarke, The lymphocyteto-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer, Ann. Surg. 265(3) (2017) 539–546; https://doi.org/10.1097/SLA.0000000000001743.
- Y. Li, H. Jia, W. Yu, Y. Xu, X. Li, Q. Li and S. Cai, Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection, Int. J. Cancer 139(1) (2016) 220–231; https://doi.org/10.1002/ijc.30071
- Y. Okugawa, Y. Toiyama, A. Yamamoto, T. Shigemori, S. Ide, T. Kitajima, H. Fujikawa, H. Yasuda, J. Hiro, S. Yoshiyama, T. Yokoe, S. Saigusa, K. Tanaka, Y. Shirai, M. Kobayashi, M. Ohi, T. Araki, D. C. McMillan, C. Miki, A. Goel and M. Kusunokit, Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer, Ann. Surg. 272(2) (2020) 342–351; https://doi.org/10.1097/SLA.0000000000003239
- S. Suzuki, T. Akiyoshi, K. Oba, F. Otsuka, T. Tominaga, T. Nagasaki, Y. Fukunaga and M. Ueno, Comprehensive comparative analysis of prognostic value of systemic inflammatory biomarkers for patients with stage ii/iii colon cancer, Ann. Surg. Oncol. 27(3) (2020) 844–852; https://doi.org/10.1245/s10434-019-07904-9
- I. D. Kostakis, A. G. Vaiopoulos, Z. Garoufalia, A. G. Papavassiliou, S. Kykalos, G. Kouraklis and G. Tsourouflis, What can preoperative blood tests tell us about colorectal cancer? JBUON 23(1) (2018) 84–95.